100 East Pratt Street,
Baltimore , MD, 21202
Baltimore , MD, 21202
Summary
The fund seeks capital appreciation in the long term by investing in large-and mid-size companies in the United States.
The investment process is designed to highlight companies in the benchmark index that are engaged in the health sciences companies.
The process focuses on companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life scienc More
Link
Directors
Mar 12, 2024- Bruce W. Duncan
- David Oestreicher
- Eric L. Veiel
- Kellye L. Walker
- Mark J. Parrell
- Melody Bianchetto
- Paul F. McBride
- Robert J. Gerrard, Jr.
- Teresa Bryce Bazemore
Chief Compliance Officer
- Armando Capasso
Fund Manager(s)
Price
- 52-Week High/Low
- $102.82 - $83.13
- Turnover
- 28.8%
- Expense Ratio
- 0.67%
Company Name |
Holding |
| Eli Lilly & Co | 12.06 % |
| UnitedHealth Group Inc | 6.45 % |
| Intuitive Surgical Inc | 4.78 % |
| Thermo Fisher Scientific Inc | 4.42 % |
| Merck & Co Inc | 3.95 % |
| Elevance Health Inc | 3.73 % |
| Stryker Corp | 3.56 % |
| Danaher Corp | 3.41 % |
| Regeneron Pharmaceuticals Inc | 3.16 % |
| Vertex Pharmaceuticals Inc | 2.55 % |
| More | 2.55 % |
Documents
Performance
YTD
4.7%
3 Year
-15.88%
5 Year
23.15%
Best
28.18%
2017
Worst
-13.59%
2022
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 8% | -2.3% | -8.6% | -0.3% | -13.4% | 15.5% | 1.4% | 11.3% | - | - |
| Q2 | -2.2% | 3.5% | -9.9% | 9.8% | 23.5% | 1.6% | 9.5% | 7.5% | 4.3% | - |
| Q3 | - | -5.4% | -2% | -6.1% | -0.5% | -8.1% | 11% | 5.3% | 2.9% | - |
| Q4 | - | 3.1% | 7% | 2.3% | 14% | 11.9% | -15.6% | 0.9% | -4.7% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2% | 4.1% | 1.7% | -3.1% | - | - | - | - | - | - | - | - |
| 2023 | 0.6% | -4.7% | 1.9% | 3.6% | -2.9% | 2.9% | -0.1% | -1.5% | -3.9% | -3.9% | 5.6% | 1% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5% | -2% | -14% | 5% | 21% | 22% | 1% | 28% | 0% | 0% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| THISX | 5% | -2% | -14% | 5% | 21% | 22% | 1% | 28% | - | - |
| S&P 500 | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% | -1% |
| Alpha | 5% | -2% | 8% | -22% | 5% | -7% | 7% | 9% | - | - |